Biomarin Pharmaceutical Inc. (BMRN) News Headlines

▮ More

Date

Headline

1/22/2020 6:24:11 AM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $158 Price Target

1/13/2020 9:32:08 AM Biomarin Pharma To Present At J.P. Morgan Conference; Webcast At 10:30 AM ET

1/13/2020 8:31:56 AM BioMarin Plans To Begin Clinical Trial With BMN 307 Gene Therapy

12/23/2019 8:37:29 AM BioMarin Submits BLA To FDA For Valoctocogene Roxaparvovec To Treat Hemophilia A

12/23/2019 8:32:25 AM EMA Validates BioMarin's Marketing Authorization Application For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A

12/16/2019 9:49:12 PM AXSM Again Proves It Is Awesome, MIRM Leaps To $22, WVE Doesn't Go The Distance

12/16/2019 8:36:33 AM BioMarin: Vosoritide Phase 3 Study Shows Positive Results - Quick Facts

12/16/2019 8:20:38 AM BioMarin Reports Positive Final Results From Phase 3 Study Evaluating Vosoritide

12/14/2019 3:14:45 AM Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

11/14/2019 8:30:47 AM BioMarin Updates On Clinical Program For Vosoritide, Analog Of C-type Natriuretic Peptide

10/23/2019 4:23:12 PM Biomarin Pharmaceutical Inc. Q3 adjusted earnings Beat Estimates

10/23/2019 4:08:50 PM BioMarin Q3 EPS $0.30 Vs. Loss $0.07 Year Ago

10/23/2019 3:02:53 PM Biomarin Pharmaceutical Q3 19 Earnings Conference Call At 4:30 PM ET

9/26/2019 8:39:19 AM BioMarin Submits Clinical Trial Application In U.K. For Investigational Gene Therapy For PKU

9/10/2019 7:37:43 AM Biomarin Pharma To Present At Morgan Stanley Conference; Webcast At 8:35 AM ET

8/1/2019 4:22:00 PM BioMarin Q2 Loss/share $0.21 Vs. Loss $0.09 Year Ago

8/1/2019 4:10:06 PM EARNINGS SUMMARY: Details of Biomarin Pharmaceutical Inc. Q2 Earnings Report

7/10/2019 6:50:34 AM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $128 Price Target

7/9/2019 8:32:29 AM BioMarin Appoints Liz McKee Anderson To Board, Effective July 15

7/8/2019 8:03:57 AM BioMarin Plans To Submit For Authorization Of Valoctocogene Roxaparvovec To Treat Severe Hemophilia A In Q4 In US,EU